Europe Market Report for Bone Growth Stimulators 2017 - MedCore is a new market research publication announced by Reportstack.
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The market for bone growth stimulators is defined in this report as external devices used to stimulate bone growth in acute and non-union fractures in long bones. The external segment is further broken-down by mode of operations (i.e. electrical and ultrasound). Bone growth stimulators related to the spine anatomy are not included in this report.
The bone growth stimulator market is witnessing a slowdown in growth due to market limiters related to the strict cost consideration of device payers, who collectively seek to negotiate lower prices. The majority of the bone growth stimulator market consists of external devices. Approximately every 9.5 out of 10 bone growth stimulators sold are external devices. Their lower average selling price, lack of requirement for additional implant surgeries, and ease of application are all beneficial features that are attractive to patients. Therefore, the popularity of external bone growth stimulation devices is expected to remain above that of their internal counterparts over the forecast period.
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The market for bone growth stimulators is defined in this report as external devices used to stimulate bone growth in acute and non-union fractures in long bones. The external segment is further broken-down by mode of operations (i.e. electrical and ultrasound). Bone growth stimulators related to the spine anatomy are not included in this report.
The bone growth stimulator market is witnessing a slowdown in growth due to market limiters related to the strict cost consideration of device payers, who collectively seek to negotiate lower prices. The majority of the bone growth stimulator market consists of external devices. Approximately every 9.5 out of 10 bone growth stimulators sold are external devices. Their lower average selling price, lack of requirement for additional implant surgeries, and ease of application are all beneficial features that are attractive to patients. Therefore, the popularity of external bone growth stimulation devices is expected to remain above that of their internal counterparts over the forecast period.
To view the table of contents and know more details, please visit Europe Market Report for Bone Growth Stimulators 2017 - MedCore.
Scope
2013-2023
2013-2023
Companies Mentioned
DePuy Synthes Stryker Zimmer Biomet Smith and Nephew Orthofix Bioventus Biomedical Tissue Technologies DJO Global Igea Acumed Wright Medical Konigsee Medartis Axomed Aap Mmplantate Aesculap Arthrex Others include: Aap Implantate AG, Acute Innovations, Advanced Orthopedic Solutions, BioPro, CarbonFix Orthopedics, Cardinal Health, Citieffe, ConMed, Covision Orthopedics, Evolutis, FH Orthopedics, Greatbatch Medical, Gruppo Bioimpianti, Inion, Intrauma, Lima Corporate, Link Orthopaedics, Medartis, Merete Medical, N-Dis, Ortomedic, TREU-Instrumente GmbH, Waldemar Link etc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
No comments:
Post a Comment